Pharmacogenetics and pharmacokinetics of rivaroxaban in patients with atrial fibrillation and chronic kidney disease

Aim. To study the possible relationship between polymorphic variants of ABCB1 (rs2032582, rs1045642, rs1128503), CYP3A5 (rs776746), CYP3A4 (rs35599367) and CYP2J2 (rs890293) genes with residual equilibrium concentrations (Cmin,ss) of rivaroxaban in patients with non-valvular atrial fibrillation (AF)...

Descrizione completa

Dettagli Bibliografici

Autori principali:	N. A. Shatalova, D. A. Sychev, K. B. Mirzaev, A. I. Kochetkov, E. Yu. Ebzeeva, V. B. Dashabylova, P. O. Bochkov, S. N. Tuchkova, S. V. Glagolev
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Столичная издательская компания 2023-11-01
Serie:	Рациональная фармакотерапия в кардиологии
Soggetti:	atrial fibrillation chronic kidney disease rivaroxaban pharmacokinetics pharmacogenetics
Accesso online:	https://www.rpcardio.online/jour/article/view/2970
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!